Bedridden Thromboprophylaxis: Dosing

Dosing

Approximately 75% of venous thromboembolism (VTE) cases occur among acutely ill non-surgical patients1

Indication:

For prophylaxis of proximal deep vein thrombosis (DVT) in patients bedridden due to a medical condition, including, but not limited to:2

  • Congestive cardiac failure (NYHA class III or IV)
  • Acute respiratory failure
  • Acute infection
  • Patients who also have a predisposing risk factor for VTE, such as age over 75 years, obesity, cancer or previous history of VTE.

Dosage:

Fragmin® 5,000 IU s.c. o.d. for up to 14 days2

References

1. Leizorovicz A et al. Circulation 2004;110:874–879.
2. Fragmin SmPC [Medical Thromboprophylaxis (5,000 IU syringes)]. Available at: https://www.medicines.org.uk/emc/product/4247

*Including, but not limited to: congestive cardiac failure (NYHA class III or IV), acute respiratory failure or acute infection, who also have a predisposing risk factor for VTE such as age over 75 years, obesity, cancer or previous history of VTE.~
†In patients with chronic renal insufficiency or acute renal failure.

PP-FRA-GBR-0154.  June 2019